-
1.发明授权Package for container of liquid medicine containing bicarbonate and pH indicator 失效含有碳酸氢盐和pH指示剂的药液容器包装公开(公告)号：US06232128B1
公开(公告)日：2001-05-15
申请号：US09202497
申请日：1998-12-16
申请人： Seiichiro Iguchi , Shino Shinomiya , Rika Hamamoto , Akiyo Abe , Masatoshi Inai , Keiichi Kawakami
发明人： Seiichiro Iguchi , Shino Shinomiya , Rika Hamamoto , Akiyo Abe , Masatoshi Inai , Keiichi Kawakami
IPC分类号： G01N2177
CPC分类号： A61J1/05 , A61J1/1462 , A61J1/16 , B65D79/02
摘要： The invention relates to a bicarbonate-containing medical solution package. The package comprises a gas-permeable plastic container holding a bicarbonate-containing medical solution and a gas-impermeable plastic packaging member containing the gas-permeable plastic container. A carbon-dioxide atmosphere is established in the space between the container and packaging member. In addition, a pH indicating device is contained within the space between the container and packaging member. The pH indicating device is a gas-permeable plastic packet containing a bicarbonate-containing fluid (similar to the medical solution) and a pH indicator. The pH indicator undergoes a change in color in response to a change in pH of the fluid. Use of this package allows the easy monitoring of a change in pH and consequent aging of the medical solution due to prolonged storage or damage to the outer packaging member.
摘要翻译： 本发明涉及含碳酸氢盐的药液包装。 该包装包括容纳含碳酸氢盐的医用溶液的透气性塑料容器和包含透气性塑料容器的不透气塑料包装构件。 在容器和包装部件之间的空间内建立二氧化碳气氛。 此外，pH指示装置容纳在容器和包装构件之间的空间内。 pH指示装置是含有含碳酸氢盐的流体（类似于药物溶液）和pH指示剂的透气塑料包装。 pH指示剂随着流体pH的变化而发生颜色变化。 使用该包装允许容易地监测由于长时间储存或损坏外包装构件而引起的pH变化和随之而来的医用溶液老化。
-
公开(公告)号：US20100075081A1
公开(公告)日：2010-03-25
申请号：US12385371
申请日：2009-04-06
CPC分类号： B32B27/32 , B32B27/08 , B32B2307/306 , B32B2307/31 , B32B2307/558 , B32B2307/7242 , B32B2307/7246 , B32B2439/40 , Y10T428/13 , Y10T428/1317 , Y10T428/1334 , Y10T428/1352 , Y10T428/2495 , Y10T428/24967 , Y10T428/269 , Y10T428/31913
摘要： ABSTRACT Disclosed is a multi-layer film comprising: a surface layer having a thickness of 10 to 50 fÊm made of an ethylene-f-olefin copolymer having a density of 0.935 to 0.950 g/cm3, a flexible layer having a thickness of 100 to 200 fÊm made of an ethylene-f-olefin copolymer having a density of 0.860 to 0.930 g/cm3, a barrier layer having a thickness of 10 to 80 fÊm made of a mixed resin containing 60 to 95% by weight of a cyclic olefin polymer and 5 to 40% by weight of an ethylene-f-olefin copolymer having a density of 0.900 to 0.965 g/cm3, and a seal layer having a thickness of 5 to 80 fÊm made of an ethylene-f-olelin copolymer having a density of 0.910 to 0.950 g/cm3. This multi-layer film is suited for use as a material for production of a medicine container 10 because it suppresses adsorption or a medicine by the barrier layer and is also superior in strength and flexibility.
摘要翻译： 摘要公开了一种多层膜，其包括：由密度为0.935至0.950g / cm 3的乙烯-α-烯烃共聚物制成的厚度为10至50埃的表层，厚度为100至 由密度为0.860〜0.930g / cm 3的乙烯-α-烯烃共聚物制成的膜，由含有60〜95重量％的环状烯烃聚合物的混合树脂制成的厚度为10〜80μm的阻隔层 和5〜40重量％的密度为0.900〜0.965g / cm 3的乙烯-α-烯烃共聚物，以及密度为5〜80的乙烯-α-烯烃共聚物，其密度为 为0.910〜0.950g / cm 3。 这种多层膜适合用作药物容器10的制造用材料，因为它抑制了阻挡层的吸附或药物，而且强度和柔软性也优异。
-
公开(公告)号：US07443117B2
公开(公告)日：2008-10-28
申请号：US11707903
申请日：2007-02-20
申请人： Tsuneyuki Egami , Keiichi Kawakami , Takashi Ogawa
发明人： Tsuneyuki Egami , Keiichi Kawakami , Takashi Ogawa
CPC分类号： B60W20/10 , B60K1/02 , B60K6/365 , B60K6/445 , B60K31/04 , B60L3/0046 , B60L11/123 , B60L11/14 , B60L15/025 , B60L2210/14 , B60L2210/20 , B60L2210/40 , B60L2220/14 , B60L2270/20 , B60W10/08 , B60W10/26 , B60W20/00 , H02P9/00 , H02P21/00 , Y02T10/6217 , Y02T10/6239 , Y02T10/643 , Y02T10/7077 , Y02T10/7225 , Y02T10/7241 , Y02T10/725
摘要： In a hybrid vehicle control apparatus, a motor control unit executes a system voltage stabilization control, in which an input power to a MG unit is controlled to suppress variations in the system voltage. The motor control unit executes the input power control on the MG unit independently from a torque control on an AC motor so that the input power control and the torque control are stabilized. Before a smoothing capacitor is sufficiently, a conversion voltage control is executed to control an output voltage of a voltage booster converter while prohibiting the system voltage stabilization control. After the pre-charging of the capacitor, the conversion voltage control is changed to the conversion power control.
摘要翻译： 在混合动力车辆控制装置中，马达控制单元执行系统稳定控制，其中控制对MG单元的输入功率以抑制系统电压的变化。 马达控制单元独立于交流马达上的转矩控制来执行MG单元上的输入功率控制，使输入功率控制和转矩控制稳定。 在平滑电容器充分之前，执行转换电压控制以控制升压转换器的输出电压，同时禁止系统稳压控制。 在电容器的预充电之后，转换电压控制变为转换功率控制。
-
公开(公告)号：US4777092A
公开(公告)日：1988-10-11
申请号：US44738
申请日：1987-05-01
申请人： Keiichi Kawakami , Mitsuo Takabatake , Jiro Chiba
发明人： Keiichi Kawakami , Mitsuo Takabatake , Jiro Chiba
IPC分类号： C04B35/00 , B32B18/00 , C03C3/066 , C03C3/093 , C03C14/00 , C04B35/111 , C04B35/16 , C04B35/18 , C04B41/51 , C04B41/88 , H01L23/15 , H05K1/03 , B32B15/00 , C03C1/00
CPC分类号： C04B41/009 , B32B18/00 , C03C14/004 , C03C3/066 , C03C3/093 , C04B35/111 , C04B35/18 , C04B41/5127 , C04B41/88 , H01L23/15 , C03C2214/04 , C04B2111/00612 , C04B2235/6567 , C04B2235/6584 , C04B2237/343 , C04B2237/68 , H01L2924/0002 , H01L2924/09701 , H05K1/0306 , Y10S428/901 , Y10T428/24917
摘要： A composition for a ceramic substrate comprising from 30 to 70% by weight of glass powder, from 28 to 70% by weight of refractory filler powder and an oxidizing agent, said glass powder consisting essentially of from 38 to 48% by weight of SiO.sub.2, from 1 to 8% by weight of Al.sub.2 O.sub.3, from 0 to 10% by weight of MgO, from 18 to 28% by weight of BaO, from 1 to 8% by weight of CaO, from 0 to 15% by weight of SrO, from 0.5 to 15% by weight of B.sub.2 O.sub.3, from 0 to 20% by weight of PbO, from 10 to 20% by weight of ZnO, from 0 to 7% by weight of TiO.sub.2 plus ZrO.sub.2 and from 0 to 5% by weight of Li.sub.2 O plus Na.sub.2 O plus K.sub.2 O, and said refractory filler powder comprising from 20 to 60% by weight of alumina, from 0 to 40% by weight of zircon, from 0 to 30% by weight of cordierite and from 0 to 30% by weight of forsterite.
摘要翻译： 一种用于陶瓷基材的组合物，其包含30至70重量％的玻璃粉末，28至70重量％的耐火填料粉末和氧化剂，所述玻璃粉末基本上由38至48重量％的SiO 2， 1〜8重量％的Al 2 O 3，0〜10重量％的MgO，18〜28重量％的BaO，1〜8重量％的CaO，0〜15重量％的SrO， 0.5至15重量％的B 2 O 3，0至20重量％的PbO，10至20重量％的ZnO，0至7重量％的TiO 2加上ZrO 2和0至5重量％ Li2O加Na2O加K2O，所述耐火填料粉末包含20至60重量％的氧化铝，0至40重量％的锆石，0至30重量％的堇青石和0至30重量％的氧化钇 镁橄榄石
-
公开(公告)号：US08377029B2
公开(公告)日：2013-02-19
申请号：US10554094
申请日：2004-04-19
CPC分类号： B65B3/022 , A61J1/067 , A61M2207/00 , B29C49/04 , B65D1/095
摘要： A drug solution filling plastic ampoule having gas, steam and light ray barrier properties, a drug permeation preventing capability and an absorption/adsorption preventing capability, and a production method for the plastic ampoule. The drug solution filling plastic ampoule includes a container body, a fusion-bonded portion which seals a mouth of the container body, and a wrench-off holder tab connected to the fusion-bonded portion. The ampoule is formed from a parison including two or more layers, at least one of which is a functional layer having at least one characteristic property selected from the group consisting of a gas permeation preventing capability, a steam permeation preventing capability, a light ray permeation preventing capability, a drug permeation preventing capability and a drug absorption/adsorption preventing capability.
摘要翻译： 填充具有气体，蒸汽和光线阻隔性能的药物溶液，药物渗透防止能力和吸收/吸附防止能力的药液以及塑料安瓿的制造方法。 填充塑料安瓿的药液包括容器主体，密封容器主体的口部的熔接部分和连接到熔接部分的扳手保持片。 安瓿由包括两层或更多层的型坯形成，其中至少一层是具有选自以下的至少一种特性的功能层：气体渗透防止能力，防蒸气渗透能力，光线渗透性 防止能力，药物渗透防止能力和药物吸收/吸附防止能力。
-
公开(公告)号：US07609023B2
公开(公告)日：2009-10-27
申请号：US11606060
申请日：2006-11-30
申请人： Tsuneyuki Egami , Keiichi Kawakami
发明人： Tsuneyuki Egami , Keiichi Kawakami
IPC分类号： H02P27/04
CPC分类号： B60L11/123 , B60K6/445 , B60L11/12 , B60L11/14 , B60L15/025 , B60L2210/20 , B60L2220/14 , B60R16/02 , B60W10/08 , B60W20/00 , H02P21/06 , Y02T10/6217 , Y02T10/6239 , Y02T10/643 , Y02T10/7077 , Y02T10/725
摘要： In electric vehicle control, system voltage stabilization control is executed to reduce the difference between a target value and detected value of a system voltage generated by a voltage boosting converter for an AC motor. Further, conversion power control is executed to reduce the difference between a command value and detected value of the conversion power, which is defined as the output power of the voltage boosting converter. A conversion power correction quantity is computed from an input power operation quantity of the system voltage stabilization control and reflected in the conversion power control to correct the conversion power. Thus, variations in a system voltage caused by an error or the conversion power control can be reduced.
摘要翻译： 在电动车辆控制中，执行系统稳定电压控制，以减小由用于交流电动机的升压转换器产生的系统电压的目标值和检测值之间的差。 此外，执行转换功率控制以减小指定值与转换功率的检测值之间的差，其被定义为升压转换器的输出功率。 转换功率校正量根据系统电压稳定控制的输入功率操作量计算并反映在转换功率控制中以校正转换功率。 因此，可以减少由误差或转换功率控制引起的系统电压的变化。
-
公开(公告)号：US07113863B2
公开(公告)日：2006-09-26
申请号：US10959418
申请日：2004-10-07
IPC分类号： F02D41/04
CPC分类号： B60W10/06 , B60W10/184 , B60W10/20 , B60W30/20 , F02D31/005 , F02D41/0002 , F02D41/021 , F02D41/1497 , F02D2200/1002 , F02D2200/501 , F02D2250/28 , Y02T10/42
摘要： A vehicle-supervising electronic control unit (VS-ECU) measures driving torque, which is outputted from an engine to a drive shaft through an automatic transmission. The VS-ECU measures road surface transmission torque based on rotation speeds of driving wheels of a vehicle, vehicle body speed and driving wheel torque, which are measured in advance. The VS-ECU compares the driving torque with the road surface transmission torque. If it is determined that the driving torque is greater than the road surface transmission torque, the VS-ECU estimates an opening degree of an air bypass valve for controlling the driving torque so that a difference between the driving torque and the road surface transmission torque is decreased.
摘要翻译： 车辆监控电子控制单元（VS-ECU）测量通过自动变速器从发动机输出到驱动轴的驱动转矩。 VS-ECU基于预先测量的车辆的驱动轮的转速，车体速度和驱动轮转矩来测量路面传递扭矩。 VS-ECU将驱动扭矩与路面传动扭矩进行比较。 如果确定驱动转矩大于路面传递转矩，则VS-ECU估计用于控制驱动转矩的空气旁通阀的开度，使得驱动转矩和路面传递转矩之间的差为 减少。
-
公开(公告)号：US20050177128A1
公开(公告)日：2005-08-11
申请号：US10509673
申请日：2003-04-25
IPC分类号： A61J1/00 , A61J1/05 , A61J1/10 , A61J1/20 , B65D30/22 , B65D33/38 , B65D77/04 , B65D77/30 , B65D81/32 , A61B19/00 , A61M5/32
CPC分类号： A61J1/2093 , A61J1/10 , A61J1/2024 , B65D81/3266 , B65D81/3272
摘要： A multiple-chamber medical container 1 comprises a container body 5 having two chambers 9, 11 for containing medicaments therein and a partitioning weak seal portion 13 for separating the chambers 9, 11 from each other, a medicinal outlet portion 7 attached to the container body 5 for discharging the medicaments from the chambers therethrough, and an openable small container 15 disposed in the first chamber 9 and having a medicament enclosed therein, the partitioning seal portion 15 being openable so as to cause the chambers 9, 11 to communicate with each other for use. The small container 15 can be opened by opening the partitioning weak seal portion 13.
摘要翻译： 多腔医疗容器1包括具有两个用于容纳药物的腔室9,11的容器主体5和用于将腔室9,11彼此分离的分隔弱密封部分13，附接到容器主体的药物出口部分7 5，用于从腔室排出药剂;以及可拆卸的小容器15，其设置在第一室9中，并且具有封闭在其中的药物，分隔密封部15可打开，使得腔室9,11彼此连通 用来。 通过打开分隔弱密封部分13可以打开小容器15。
-
公开(公告)号：US06461633B1
公开(公告)日：2002-10-08
申请号：US09463309
申请日：2000-01-24
申请人： Keiichi Kawakami , Katsushi Watanabe , Teru Nakai , Katsumi Uei , Aya Bandou , Tatsuya Ishii , Yuki Hirata , Takashi Fujimoto
发明人： Keiichi Kawakami , Katsushi Watanabe , Teru Nakai , Katsumi Uei , Aya Bandou , Tatsuya Ishii , Yuki Hirata , Takashi Fujimoto
IPC分类号： A61K4700
CPC分类号： A23L33/12
摘要： The invention provides a reducing sugar-containing fat emulsion comprising an oil-in-water fat emulsion available upon emulsification of a fat with an emulsifier wherein a reducing sugar and at least one buffer substance selected from among organic acids with acid dissociation exponents in water within the range of 5.0-7.5 and their salts are concurrently contained in the water phase thereof, with the emulsion having been adjusted to pH 5.0-7.5; a reducing sugar-containing fat emulsion product which comprises a medicinal fluid containing a reducing sugar and a fat as sterilized with carbon dioxide gas dissolved therein and contained in a plastic infusion container, said plastic infusion container being accommodated together with a carbon dioxide gas absorber in a substantially oxygen-impermeable secondary container; and a method for their preparation and sterilization. The reducing sugar-containing fat emulsion is stable and of high quality, because it is inhibited against formation of free fatty acids, decomposition of the reducing sugar, and hence coloration.
摘要翻译： 本发明提供一种含还原糖的脂肪乳剂，其包含在用乳化剂乳化脂肪时可获得的水包油型脂肪乳剂，其中还原糖和选自有机酸中的至少一种缓冲物质，在水中具有酸解离指数 在其水相中同时含有5.0-7.5的范围及其盐，将乳液调节至pH5.0-7.5; 含有还原糖的脂肪乳液产品，其包含含有还原糖和脂肪的药液，所述药液用溶解在其中的二氧化碳气体灭菌并包含在塑料输注容器中，所述塑料输注容器与二氧化碳气体吸收器一起容纳 基本上不透氧的次级容器; 及其制备和灭菌方法。 含还原糖的脂肪乳液是稳定的和高质量的，因为它被抑制游离脂肪酸的形成，还原糖的分解和着色。
-
公开(公告)号：US08343128B2
公开(公告)日：2013-01-01
申请号：US10509673
申请日：2003-04-25
CPC分类号： A61J1/2093 , A61J1/10 , A61J1/2024 , B65D81/3266 , B65D81/3272
摘要： A multiple-chamber medical container 1 comprises a container body 5 having two chambers 9, 11 for containing medicaments therein and a partitioning weak seal portion 13 for separating the chambers 9, 11 from each other, a medicinal outlet portion 7 attached to the container body 5 for discharging the medicaments from the chambers therethrough, and an openable small container 15 disposed in the first chamber 9 and having a medicament enclosed therein, the partitioning seal portion 15 being openable so as to cause the chambers 9, 11 to communicate with each other for use. The small container 15 can be opened by opening the partitioning weak seal portion 13.
摘要翻译： 多腔医疗容器1包括具有两个用于容纳药物的腔室9,11的容器主体5和用于将腔室9,11彼此分离的分隔弱密封部分13，附接到容器主体的药物出口部分7 5，用于从腔室排出药剂;以及可拆卸的小容器15，其设置在第一室9中，并且具有封闭在其中的药物，分隔密封部15可打开，使得腔室9,11彼此连通 用来。 通过打开分隔弱密封部分13可以打开小容器15。
-
-
-
-
-
-
-
-
-
搜索结果
30 条记录 (耗时 0.027 秒)
